RCKT 8-K 2026-09-15

ROCKET PHARMACEUTICALS, INC. (RCKT) 8-K dated 2026-09-15 — accession 0001140361-26-036563.

ROCKET PHARMACEUTICALS, INC. (RCKT) is a biotechnology company listed on US.

ROCKET PHARMACEUTICALS, INC. filed a 8-K on 2026-09-15. Accession 0001140361-26-036563.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RCKT revenue for 2025-12-31 was $0. Net income was -$223.1M. RCKT currently screens at market cap $279.0M.

Not investment advice. The RCKT SEC hub lists recent forms. The stock page is the research view.